Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 63 (RPL31P63)

Target: RPL31P63
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L31 pseudogene 63 (RPL31P63) is a non-coding genomic sequence in humans corresponding to the functional ribosomal protein L31 gene (RPL31). RPL31 is a structural component of the large (60S) ribosomal subunit involved in protein synthesis. However, as a pseudogene, RPL31P63 itself does not produce a functional protein, is not implicated in disease or therapeutics, and is not a drug target.

Other names: RPL31_36_1782RPL31P63

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 63 (RPL31P63).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 63 (RPL31P63).

Explore the full profile